WO2002030874A3 - Aliphatic, cyclic amino carboxylic acids as integrin antagonists - Google Patents
Aliphatic, cyclic amino carboxylic acids as integrin antagonists Download PDFInfo
- Publication number
- WO2002030874A3 WO2002030874A3 PCT/EP2001/011584 EP0111584W WO0230874A3 WO 2002030874 A3 WO2002030874 A3 WO 2002030874A3 EP 0111584 W EP0111584 W EP 0111584W WO 0230874 A3 WO0230874 A3 WO 0230874A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aliphatic
- carboxylic acids
- cyclic amino
- amino carboxylic
- integrin antagonists
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/28—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C275/40—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
- C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
- C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
- C07C323/60—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton with the carbon atom of at least one of the carboxyl groups bound to nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2002215926A AU2002215926A1 (en) | 2000-10-09 | 2001-10-08 | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0024692.6 | 2000-10-09 | ||
GB0024692A GB2369357A (en) | 2000-10-09 | 2000-10-09 | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002030874A2 WO2002030874A2 (en) | 2002-04-18 |
WO2002030874A3 true WO2002030874A3 (en) | 2002-07-25 |
Family
ID=9900922
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2001/011584 WO2002030874A2 (en) | 2000-10-09 | 2001-10-08 | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
Country Status (3)
Country | Link |
---|---|
AU (1) | AU2002215926A1 (en) |
GB (1) | GB2369357A (en) |
WO (1) | WO2002030874A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2377933A (en) | 2001-07-06 | 2003-01-29 | Bayer Ag | Succinic acid derivatives useful as integrin antagonists |
WO2005067502A2 (en) * | 2004-01-02 | 2005-07-28 | Merck & Co., Inc. | Alkylamino, arylamino, and sulfonamido cyclopentyl amide modulators of chemokine receptor activity |
US8614238B2 (en) | 2009-10-19 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Cyclopentanecarboxamide derivatives, medicaments containing such compounds and their use |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033789A1 (en) * | 1997-12-23 | 1999-07-08 | Aventis Pharma Limited | SUBSTITUTED β-ALANINES |
WO1999037605A1 (en) * | 1998-01-23 | 1999-07-29 | Novartis Ag | Vla-4 antagonists |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SG158733A1 (en) * | 1996-07-25 | 2010-02-26 | Biogen Idec Inc | Cell adhesion inhibitors |
GB9909409D0 (en) * | 1999-04-24 | 1999-06-23 | Zeneca Ltd | Chemical compounds |
-
2000
- 2000-10-09 GB GB0024692A patent/GB2369357A/en not_active Withdrawn
-
2001
- 2001-10-08 AU AU2002215926A patent/AU2002215926A1/en not_active Abandoned
- 2001-10-08 WO PCT/EP2001/011584 patent/WO2002030874A2/en active Application Filing
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1999033789A1 (en) * | 1997-12-23 | 1999-07-08 | Aventis Pharma Limited | SUBSTITUTED β-ALANINES |
WO1999037605A1 (en) * | 1998-01-23 | 1999-07-29 | Novartis Ag | Vla-4 antagonists |
Also Published As
Publication number | Publication date |
---|---|
AU2002215926A1 (en) | 2002-04-22 |
GB2369357A (en) | 2002-05-29 |
WO2002030874A2 (en) | 2002-04-18 |
GB0024692D0 (en) | 2000-11-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MY142029A (en) | Phenoxyacetic acid derivatives | |
SE0301010D0 (en) | Novel compounds | |
SE0301009D0 (en) | Novel compounds | |
WO2001019776A3 (en) | Novel derivatives of dicarboxylic acid having pharmaceutical properties | |
WO2001019780A3 (en) | Novel derivatives of dicarboxylic acid having pharmaceutical properties | |
MY149181A (en) | Isoxazoline derivative and preparation process thereof | |
DK1086124T3 (en) | New cyclosporins | |
MX2008014101A (en) | 4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments. | |
CA2400268A1 (en) | Pyrrolopyrimidinone derivatives, process of preparation and use | |
WO2002048147A3 (en) | Pyrazolopyridines | |
WO2007099553A3 (en) | 1,3-dioxane carboxylic acids | |
WO2005033099A3 (en) | Novel dipeptidyl peptidase iv inhibitors; processes for their preparation and compositions thereof | |
JO2493B1 (en) | Novel diphenylazetidione, Process for its preparation, medicaments comprising this compound and their use | |
WO2006117211A3 (en) | Urea derivatives methods for their manufacture and uses thereof | |
WO2001096307A3 (en) | Cycloalkyl alkanoic acids as integrin receptor antagonists | |
DOP2002000512A (en) | SUCCINATE ACID SALTS OF 5,7,14-TRIAZATETRACICLO [10.3.1.0² ¹¹.04,9] HEXADECA-2 (11), 3,5,7,9-PENTAENE AND PHARMACEUTICAL COMPOSITIONS OF THE SAME | |
IL160171A0 (en) | Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same | |
WO2005040171A8 (en) | Pyrazolo and imidazo-pyrimidine derivatives | |
HK1057897A1 (en) | 4-Alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof. | |
WO2007002128A3 (en) | Compositions comprising and processes for producing inorganic salts of hop acids | |
WO2005055943A3 (en) | Vinorelbine derivatives | |
WO2001081298A3 (en) | Cyclic carboxylic acids as integrin antagonists | |
WO2004106307A3 (en) | Novel imidazole derivatives, the production thereof, and the use of the same as a medicament | |
TNSN06233A1 (en) | 7-phenylamino-4-quinolone-3-carboxylic acid derivatives, methods for production and use thereof as medicaments | |
WO2002030874A3 (en) | Aliphatic, cyclic amino carboxylic acids as integrin antagonists |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PH PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |